Akso Health Group (AHG)
1.27
-0.06
(-4.51%)
USD |
NASDAQ |
Nov 17, 16:00
1.27
0.00 (0.00%)
After-Hours: 20:00
Akso Health Group Enterprise Value : 1.145B for Nov. 16, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 16, 2026 | 1.145B |
| November 13, 2026 | 1.068B |
| November 12, 2026 | 1.157B |
| November 11, 2026 | 1.162B |
| November 10, 2026 | 1.075B |
| November 09, 2026 | 1.102B |
| November 06, 2026 | 1.162B |
| November 05, 2026 | 1.115B |
| November 04, 2026 | 1.145B |
| November 03, 2026 | 1.042B |
| November 02, 2026 | 1.130B |
| October 30, 2026 | 1.085B |
| October 29, 2026 | 1.145B |
| October 28, 2026 | 1.119B |
| October 27, 2026 | 1.213B |
| October 26, 2026 | 1.093B |
| October 23, 2026 | 1.119B |
| October 22, 2026 | 1.051B |
| October 21, 2026 | 1.093B |
| October 20, 2026 | 1.056B |
| October 19, 2026 | 1.145B |
| October 16, 2026 | 1.162B |
| October 15, 2026 | 1.162B |
| October 14, 2026 | 1.183B |
| October 13, 2026 | 1.169B |
| Date | Value |
|---|---|
| October 12, 2026 | 1.179B |
| October 09, 2026 | 1.076B |
| October 08, 2026 | 982.28M |
| October 07, 2026 | 1.042B |
| October 06, 2026 | 1.008B |
| October 05, 2026 | 999.36M |
| October 02, 2026 | 990.82M |
| October 01, 2026 | 879.79M |
| September 30, 2026 | 777.30M |
| September 29, 2026 | 598.81M |
| September 28, 2026 | 632.97M |
| September 25, 2026 | 649.20M |
| September 24, 2026 | 657.74M |
| September 23, 2026 | 666.19M |
| September 22, 2026 | 640.74M |
| September 21, 2026 | 657.74M |
| September 18, 2026 | 650.31M |
| September 17, 2026 | 649.20M |
| September 16, 2026 | 645.01M |
| September 15, 2026 | 657.74M |
| September 14, 2026 | 693.44M |
| September 11, 2026 | 725.38M |
| September 10, 2026 | 632.29M |
| September 09, 2026 | 691.99M |
| September 08, 2026 | 706.25M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Interpace Biosciences, Inc. | 32.64M |
| Concord Medical Services Holdings Ltd. | -- |
| Exlites Holdings International, Inc. | 15.42M |
| Xcelerate, Inc. | 11.11M |
| Fresenius SE & Co. KGaA | 45.10B |
Enterprise Value Related Metrics
| Earnings Yield | -1.78% |
| Normalized Earnings Yield | -0.7008 |